450: 10891094, doi: Liao CD, Tsauo JY, Wu YT, Cheng CP, Chen HC, Huang YC, Chen HC, Liou TH
Metabolic improvements from GLP-1 therapy may benefit breast cancer survivors, as obesity and insulin resistance are associated with poorer cancer outcomes
Clinical studies indicate that metabolic improvements gained during GLP-1 therapy can persist for weeks to months after stopping, but they gradually fade
Pharmacol Ther (2013) 140(3):23957
Understanding BPC-157: Debunking Misconceptions and Exploring Its Potentials Introduction Welcome to a special edition of the Human Longevity Podcast, where we dive deep into the misconceptions and scientific truths about peptides, particularly BPC-157
The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney